Literature DB >> 8747351

Intermediate follow-up of a simple method of hip arthrodesis in adolescent patients.

T E Benaroch1, B S Richards, N Haideri, C Smith.   

Abstract

Thirteen male patients (average age, 15.6 years) underwent intraarticular hip arthrodesis for unilateral disabling hip disease. Follow-up averaged 6.6 years. Seven patients had excellent or good Harris hip scores. Ten patients had low back pain, and seven patients had knee pain on the side of the fused hip. Limb-length discrepancy averaged 3.7 cm. A progressive hip adduction drift (average, 7 degrees) occurred during follow-up. Patients whose hips were fused in a position of 20-25 degrees flexion and whose limb-length discrepancies were < 2 cm had significantly lower incidences of back pain. Cybex muscle testing revealed significantly decreased quadriceps strength (29%) on the hip-fusion side. Gait laboratory analysis demonstrated decreased velocity, stride length, and cadence. There were two mildly symptomatic nonunions. Based on these results, we recommend that the hip fusion be positioned in 20 degrees flexion and 0 degree abduction. The joint must be completely debrided down to viable bone to maximize chances for union. Maintaining a limb-length discrepancy of < 2 cm is essential to minimize the incidence of low back pain, quadriceps deficiency, and abnormal gait parameters.

Entities:  

Mesh:

Year:  1996        PMID: 8747351     DOI: 10.1097/00004694-199601000-00007

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  3 in total

1.  [Arthrodesis of the hip and its conversion].

Authors:  G Zeiler; A Schuh
Journal:  Orthopade       Date:  2004-08       Impact factor: 1.087

2.  Hip arthrodesis in the pediatric population: where do we stand?

Authors:  Bernd Bittersohl; Daniela Zaps; James D Bomar; Harish S Hosalkar
Journal:  Orthop Rev (Pavia)       Date:  2011-06-29

3.  Hip arthrodesis with the anterolateral plate: an innovating technique for an orphaned procedure.

Authors:  Patrick Hoekman; Garba Idé; Akambi Sanoussi Kassoumou; Mahamadou Malam Hayatou
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.